Immunomedics (IMMU) Misses Q1 EPS by 86c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q1 EPS of ($0.97), $0.86 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $690.49 million, versus $741.81 million reported last year.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OppFi Inc. (OPFI) Tops Q3 EPS by 2c ; Offers Guidance
- Materialise NV (MTLS) Reports In-Line Q3 EPS; reaffirms outlook
- Banco Santander S.A. (SAN) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
